Clinical Trials Browser

OTHER × Fibrocystic Breast Disease × Breast × Clear all

Breast Neoplasms, Colonic Neoplasms, Fibrocystic Breast Disease, Gastrointestinal Diseases, Lung Neoplasms, Neoplasms, Prostatic Neoplasms, Skin Neoplasms, Colorectal Neoplasms

NCT03979508 2025-11-12

Abemaciclib in Treating Patients With Surgically Resectable, Chemotherapy Resistant, Triple Negative Breast Cancer

Phase 2 Terminated

26 enrolled

Breast

Breast Carcinoma In Situ, Carcinoma, Intraductal, Noninfiltrating, Fibrocystic Breast Disease, Triple Negative Breast Neoplasms

NCT00826488 2015-06-02

A Comparison of Breast Tomosynthesis Mammography and Conventional Breast Imaging in the Characterization of Breast Masses

Phase EARLY_PHASE1 Completed

136 enrolled

Breast

Breast Neoplasms, Fibrocystic Breast Disease

NCT00999921 2015-05-18

Effects of Tamoxifen in Premenopausal Women With Benign Breast Disease Not at High-Risk of Developing Breast Cancer

Phase 4 Completed

256 enrolled 8 charts

Breast

Cystic Fibrosis, Fibrocystic Breast Disease, Fibroadenoma, Mastodynia

NCT00310882 2011-04-08

Involvement of Endogenous Digitalis-like Compounds in Breast Cancer

Withdrawn

250 enrolled

Breast

Breast Neoplasms, Fibrocystic Breast Disease

Clinical Trials

A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials

Abemaciclib in Treating Patients With Surgically Resectable, Chemotherapy Resistant, Triple Negative Breast Cancer

A Comparison of Breast Tomosynthesis Mammography and Conventional Breast Imaging in the Characterization of Breast Masses

Effects of Tamoxifen in Premenopausal Women With Benign Breast Disease Not at High-Risk of Developing Breast Cancer

Involvement of Endogenous Digitalis-like Compounds in Breast Cancer